Effect of hemodilution with dextran, stroma-free hemoglobin solution and fluosol-DA on experimental myocardial ischemia in the dog.
D000818:Animals; D001802:Blood Substitutes / Q000627:therapeutic use*; D002302:Cardiac Output; D003326:Coronary Circulation; D003911:Dextrans / Q000627:therapeutic use; D004285:Dogs; D004338:Drug Combinations / Q000627:therapeutic use; D005466:Fluorocarbons / Q000627:therapeutic use; D006400:Hematocrit; D006438:Hemodilution / Q000379:methods*; D006895:Hydroxyethyl Starch Derivatives; D009203:Myocardial Infarction / Q000097:blood / Q000503:physiopathology / Q000628:therapy*; D010100:Oxygen / Q000097:blood
D001802:Blood Substitutes; D003911:Dextrans; D004338:Drug Combinations; D005466:Fluorocarbons; D006895:Hydroxyethyl Starch Derivatives; C017323:glucose, glycerol, hydroxyethyl starch, perfluorodecalin, perfluorotripropylamine, pluronic F-68, salts, yolk phospholipids drug combination; D010100:Oxygen